Middle Cerebral Artery Stroke Clinical Trial
Official title:
A Phase IIa Randomized, Double-Blind, Parallel-Groups, Placebo Controlled Clinical Trial to Study the Efficacy and Safety of MK0724 Intravenous Infusion on the Amelioration of Neurological Damage and Recovery From Middle Cerebral Artery Ischemic Stroke
The safety and efficacy of MK0724 will be assessed in patients with acute middle cerebral artery stroke using the Action Reach Arm Test (ARAT). This test allows measurement of a specific functional deficit and subsequent recovery correlating with the specific area of stroke in the brain.
n/a
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03364634 -
Intracranial Pressure After Decompressive Craniectomy
|
N/A | |
| Completed |
NCT03752788 -
Dual-Task Training With Different Priority Instructional Sets on the Gait Parameters in Patients With Chronic Stroke
|
N/A | |
| Terminated |
NCT01310114 -
Study of Human Placenta-derived Cells (PDA001) to Evaluate the Safety and Effectiveness for Patients With Ischemic Stroke
|
Phase 2 | |
| Withdrawn |
NCT04000269 -
HD-tDCs to Improve Upper Extremity Function in Patients With Acute Middle Cerebral Artery Stroke
|
N/A | |
| Completed |
NCT00604630 -
Multicenter Efficacy Study of Recombinant Human Erythropoietin in Acute Ischemic Stroke
|
Phase 2/Phase 3 | |
| Recruiting |
NCT04858841 -
Post-stroke Epilepsy: Primary Prophylaxis Study
|
N/A |